Endocrine Abstracts

Introduction: Antithyroidal drug (ATD) therapy is considered as choice of treatment for Graves’ disease; however, the response of treatment varied between patients. Although several studies reported risk factors for relapse after initial treatment, there were few studies for the responsiveness during early treatment period.Method and design: We reviewed 94 patients with Graves’ disease and used their initial TSH receptor antibody (TSHRAb) titre...

Background: The acitivity of the TSH receptor stimulating antibody is known to be associated with Graves’ eye disease. However, the association between antibody titer and thyroid function was not significant, in previous studies. Taking into account the continuous changes in antibody titer and thyroid function during treatment, the association between thyroid function and clinical factors needed to be analyzed using panel analysis.Methods: A total o...